The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Personalized Cancer Medicine Market Research Report 2025
Synopsis
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
The global Personalized Cancer Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Personalized Cancer Medicine in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Medicine.
Report Scope
The Personalized Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
The global Personalized Cancer Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Personalized Cancer Medicine in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Medicine.
Report Scope
The Personalized Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Personalized Cancer Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Personalized Cancer Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)
2.2 Personalized Cancer Medicine Growth Trends by Region
2.2.1 Global Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)
2.3 Personalized Cancer Medicine Market Dynamics
2.3.1 Personalized Cancer Medicine Industry Trends
2.3.2 Personalized Cancer Medicine Market Drivers
2.3.3 Personalized Cancer Medicine Market Challenges
2.3.4 Personalized Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Medicine Players by Revenue
3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2019-2024)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
3.4 Global Personalized Cancer Medicine Market Concentration Ratio
3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023
3.5 Personalized Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Medicine Product Solution and Service
3.7 Date of Enter into Personalized Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Medicine Breakdown Data by Type
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2019-2024)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030)
5 Personalized Cancer Medicine Breakdown Data by Application
5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Cancer Medicine Market Size (2019-2030)
6.2 North America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Personalized Cancer Medicine Market Size by Country (2019-2024)
6.4 North America Personalized Cancer Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)
7.2 Europe Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)
7.4 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2019-2030)
8.2 Asia-Pacific Personalized Cancer Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Medicine Market Size (2019-2030)
9.2 Latin America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)
9.4 Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2019-2030)
10.2 Middle East & Africa Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Personalized Cancer Medicine Introduction
11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Personalized Cancer Medicine Introduction
11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Cancer Medicine Introduction
11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Personalized Cancer Medicine Introduction
11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)
11.4.5 Amgen Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Personalized Cancer Medicine Introduction
11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Personalized Cancer Medicine Introduction
11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Cancer Medicine Introduction
11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Astellas
11.8.1 Astellas Company Detail
11.8.2 Astellas Business Overview
11.8.3 Astellas Personalized Cancer Medicine Introduction
11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2019-2024)
11.8.5 Astellas Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Detail
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Personalized Cancer Medicine Introduction
11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024)
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Agilent
11.11.1 Agilent Company Detail
11.11.2 Agilent Business Overview
11.11.3 Agilent Personalized Cancer Medicine Introduction
11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2019-2024)
11.11.5 Agilent Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda Personalized Cancer Medicine Introduction
11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)
11.12.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Personalized Cancer Vaccines
Table 4. Key Players of Other
Table 5. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Personalized Cancer Medicine Market Share by Region (2019-2024)
Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Personalized Cancer Medicine Market Share by Region (2025-2030)
Table 11. Personalized Cancer Medicine Market Trends
Table 12. Personalized Cancer Medicine Market Drivers
Table 13. Personalized Cancer Medicine Market Challenges
Table 14. Personalized Cancer Medicine Market Restraints
Table 15. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Personalized Cancer Medicine Market Share by Players (2019-2024)
Table 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Table 18. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Personalized Cancer Medicine Product Solution and Service
Table 22. Date of Enter into Personalized Cancer Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2019-2024)
Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2025-2030)
Table 28. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Personalized Cancer Medicine Revenue Market Share by Application (2019-2024)
Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Personalized Cancer Medicine Revenue Market Share by Application (2025-2030)
Table 32. North America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Personalized Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Personalized Cancer Medicine Product
Table 50. Abbott Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Personalized Cancer Medicine Product
Table 55. Merck Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Personalized Cancer Medicine Product
Table 60. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Amgen Company Detail
Table 63. Amgen Business Overview
Table 64. Amgen Personalized Cancer Medicine Product
Table 65. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Celgene Company Detail
Table 68. Celgene Business Overview
Table 69. Celgene Personalized Cancer Medicine Product
Table 70. Celgene Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 71. Celgene Recent Development
Table 72. Bayer Company Detail
Table 73. Bayer Business Overview
Table 74. Bayer Personalized Cancer Medicine Product
Table 75. Bayer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Roche Company Detail
Table 78. Roche Business Overview
Table 79. Roche Personalized Cancer Medicine Product
Table 80. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Astellas Company Detail
Table 83. Astellas Business Overview
Table 84. Astellas Personalized Cancer Medicine Product
Table 85. Astellas Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 86. Astellas Recent Development
Table 87. Astrazeneca Company Detail
Table 88. Astrazeneca Business Overview
Table 89. Astrazeneca Personalized Cancer Medicine Product
Table 90. Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 91. Astrazeneca Recent Development
Table 92. Johnson & Johnson Company Detail
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Personalized Cancer Medicine Product
Table 95. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Agilent Company Detail
Table 98. Agilent Business Overview
Table 99. Agilent Personalized Cancer Medicine Product
Table 100. Agilent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 101. Agilent Recent Development
Table 102. Takeda Company Detail
Table 103. Takeda Business Overview
Table 104. Takeda Personalized Cancer Medicine Product
Table 105. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 106. Takeda Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Personalized Cancer Medicine Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Personalized Cancer Vaccines Features
Figure 5. Other Features
Figure 6. Global Personalized Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Chronic Myeloid Leukaemia Case Studies
Figure 11. Bowel Cancer Case Studies
Figure 12. Other Cancer Case Studies
Figure 13. Personalized Cancer Medicine Report Years Considered
Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030
Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2023
Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023
Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 22. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 26. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2019-2030)
Figure 34. China Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 42. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 46. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 51. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 52. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 54. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 55. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 56. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 58. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 59. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
